Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.
Z Jin, Q Gao, K Wu, J Ouyang, W Guo… - Advanced Drug Delivery …, 2023 - europepmc.org
The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
Z Jin, Q Gao, K Wu, J Ouyang, W Guo… - Advanced drug delivery … - pubmed.ncbi.nlm.nih.gov
The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …